203 related articles for article (PubMed ID: 19605523)
1. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
Li J; Wilson A; Gao X; Kuruba R; Liu Y; Poloyac S; Pitt B; Xie W; Li S
J Pharmacol Exp Ther; 2009 Oct; 331(1):234-43. PubMed ID: 19605523
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation.
Hu T; Chouinard M; Cox AL; Sipes P; Marcelo M; Ficorilli J; Li S; Gao H; Ryan TP; Michael MD; Michael LF
J Biol Chem; 2006 Dec; 281(52):39831-8. PubMed ID: 17065154
[TBL] [Abstract][Full Text] [Related]
3. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
Davids M; Richir MC; Visser M; Ellger B; van den Berghe G; van Leeuwen PA; Teerlink T
Metabolism; 2012 Apr; 61(4):482-90. PubMed ID: 22000584
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
5. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
6. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
Ferrigno A; Di Pasqua LG; Berardo C; Siciliano V; Rizzo V; Adorini L; Richelmi P; Vairetti M
PLoS One; 2018; 13(1):e0191430. PubMed ID: 29346429
[TBL] [Abstract][Full Text] [Related]
7. The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
Speranza L; Franceschelli S; D'Orazio N; Gaeta R; Bucciarelli T; Felaco M; Grilli A; Riccioni G
Microvasc Res; 2011 Nov; 82(3):391-6. PubMed ID: 21722652
[TBL] [Abstract][Full Text] [Related]
8. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Palm F; Onozato ML; Luo Z; Wilcox CS
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
[TBL] [Abstract][Full Text] [Related]
9. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Desai A; Zhao Y; Warren JS
Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
[TBL] [Abstract][Full Text] [Related]
11. L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells.
Wang J; Sim AS; Wang XL; Wilcken DE
Cell Mol Life Sci; 2006 Dec; 63(23):2838-46. PubMed ID: 17075694
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
13. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
Wakino S; Hayashi K; Tatematsu S; Hasegawa K; Takamatsu I; Kanda T; Homma K; Yoshioka K; Sugano N; Saruta T
Hypertens Res; 2005 Mar; 28(3):255-62. PubMed ID: 16097370
[TBL] [Abstract][Full Text] [Related]
15. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
16. FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats.
Ghebremariam YT; Yamada K; Lee JC; Johnson CL; Atzler D; Anderssohn M; Agrawal R; Higgins JP; Patterson AJ; Böger RH; Cooke JP
PLoS One; 2013; 8(4):e60653. PubMed ID: 23593273
[TBL] [Abstract][Full Text] [Related]
17. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
Bell T; Araujo M; Luo Z; Tomlinson J; Leiper J; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F74-F78. PubMed ID: 29513072
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
Wang D; Gill PS; Chabrashvili T; Onozato ML; Raggio J; Mendonca M; Dennehy K; Li M; Modlinger P; Leiper J; Vallance P; Adler O; Leone A; Tojo A; Welch WJ; Wilcox CS
Circ Res; 2007 Sep; 101(6):627-35. PubMed ID: 17673667
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
[TBL] [Abstract][Full Text] [Related]
20. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.
Ferrigno A; Rizzo V; Bianchi A; Di Pasqua LG; Berardo C; Richelmi P; Vairetti M
Biomed Res Int; 2014; 2014():627434. PubMed ID: 25243167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
